Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors.
Saved in:
| Title: | Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. |
|---|---|
| Authors: | Goebel L; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Kirschner T; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Koska S; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rai A; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Janning P; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Maffini S; Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Vatheuer H; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Czodrowski P; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Goody RS; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Müller MP; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rauh D; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany. |
| Source: | ELife [Elife] 2023 Mar 27; Vol. 12. Date of Electronic Publication: 2023 Mar 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
